» Articles » PMID: 37351738

Meibomian Gland Dysfunction Clinical Practice Guidelines

Overview
Specialty Ophthalmology
Date 2023 Jun 23
PMID 37351738
Authors
Affiliations
Soon will be listed here.
Citing Articles

Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model.

Sato S, Ogawa Y, Asai K, Shimizu E, Shimizu S, Taniguchi H Sci Rep. 2025; 15(1):532.

PMID: 39748084 PMC: 11696563. DOI: 10.1038/s41598-024-84380-6.


Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction.

Shimazaki J, Kito G, Kamoi M, Satake Y Jpn J Ophthalmol. 2024; 68(5):472-481.

PMID: 39002075 PMC: 11420373. DOI: 10.1007/s10384-024-01079-x.


The ILux compared to the mechanical meibomian gland expression for the treatment of moderate and severe meibomian gland dysfunction.

Nunez M, Acosta-Ortega A, Vera-Duarte G, Gomez-Duarte C Int J Ophthalmol. 2024; 17(6):1042-1048.

PMID: 38895679 PMC: 11144778. DOI: 10.18240/ijo.2024.06.08.


Standardization of meibomian gland dysfunction in an Egyptian population sample using a non-contact meibography technique.

Karara A, El-Sanabary Z, El-Helw M, Macky T, Abdelhakim M Int J Ophthalmol. 2024; 17(1):61-65.

PMID: 38239941 PMC: 10754661. DOI: 10.18240/ijo.2024.01.08.


The Yin and Yang of non-immune and immune responses in meibomian gland dysfunction.

Beatty C, Ruiz-Lozano R, Quiroga-Garza M, Perez V, Jester J, Saban D Ocul Surf. 2024; 32:81-90.

PMID: 38224775 PMC: 11881750. DOI: 10.1016/j.jtos.2024.01.004.

References
1.
Nichols K, Foulks G, Bron A, Glasgow B, Dogru M, Tsubota K . The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011; 52(4):1922-9. PMC: 3072157. DOI: 10.1167/iovs.10-6997a. View

2.
Hwang H, Parfitt G, Brown D, Jester J . Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD). Exp Eye Res. 2017; 163:37-45. PMC: 5561533. DOI: 10.1016/j.exer.2017.02.008. View

3.
Amano S, Inoue K . Clinic-Based Study on Meibomian Gland Dysfunction in Japan. Invest Ophthalmol Vis Sci. 2017; 58(2):1283-1287. DOI: 10.1167/iovs.16-21374. View

4.
Amano S, Inoue K . Estimation of Prevalence of Meibomian Gland Dysfunction in Japan. Cornea. 2017; 36(6):684-688. DOI: 10.1097/ICO.0000000000001208. View

5.
Arita R, Mizoguchi T, Kawashima M, Fukuoka S, Koh S, Shirakawa R . Meibomian Gland Dysfunction and Dry Eye Are Similar but Different Based on a Population-Based Study: The Hirado-Takushima Study in Japan. Am J Ophthalmol. 2019; 207:410-418. DOI: 10.1016/j.ajo.2019.02.024. View